Diagnosis of Alzheimer’s Disease with Ensemble Learning Classifier and 3D Convolutional Neural Network

Alzheimer’s disease (AD), the most common type of dementia, is a progressive disease beginning with mild memory loss, possibly leading to loss of the ability to carry on a conversation and respond to environments. It can seriously affect a person’s ability to carry out daily activities. Therefore, e...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Peng Zhang, Shukuan Lin, Jianzhong Qiao, Yue Tu
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/ef23e82ff19944889342ed459fd053fc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ef23e82ff19944889342ed459fd053fc
record_format dspace
spelling oai:doaj.org-article:ef23e82ff19944889342ed459fd053fc2021-11-25T18:58:06ZDiagnosis of Alzheimer’s Disease with Ensemble Learning Classifier and 3D Convolutional Neural Network10.3390/s212276341424-8220https://doaj.org/article/ef23e82ff19944889342ed459fd053fc2021-11-01T00:00:00Zhttps://www.mdpi.com/1424-8220/21/22/7634https://doaj.org/toc/1424-8220Alzheimer’s disease (AD), the most common type of dementia, is a progressive disease beginning with mild memory loss, possibly leading to loss of the ability to carry on a conversation and respond to environments. It can seriously affect a person’s ability to carry out daily activities. Therefore, early diagnosis of AD is conducive to better treatment and avoiding further deterioration of the disease. Magnetic resonance imaging (MRI) has become the main tool for humans to study brain tissues. It can clearly reflect the internal structure of a brain and plays an important role in the diagnosis of Alzheimer’s disease. MRI data is widely used for disease diagnosis. In this paper, based on MRI data, a method combining a 3D convolutional neural network and ensemble learning is proposed to improve the diagnosis accuracy. Then, a data denoising module is proposed to reduce boundary noise. The experimental results on ADNI dataset demonstrate that the model proposed in this paper improves the training speed of the neural network and achieves 95.2% accuracy in AD vs. NC (normal control) task and 77.8% accuracy in sMCI (stable mild cognitive impairment) vs. pMCI (progressive mild cognitive impairment) task in the diagnosis of Alzheimer’s disease.Peng ZhangShukuan LinJianzhong QiaoYue TuMDPI AGarticleAlzheimer’s diseaseconvolutional neural networkensemble learningdata denoisingChemical technologyTP1-1185ENSensors, Vol 21, Iss 7634, p 7634 (2021)
institution DOAJ
collection DOAJ
language EN
topic Alzheimer’s disease
convolutional neural network
ensemble learning
data denoising
Chemical technology
TP1-1185
spellingShingle Alzheimer’s disease
convolutional neural network
ensemble learning
data denoising
Chemical technology
TP1-1185
Peng Zhang
Shukuan Lin
Jianzhong Qiao
Yue Tu
Diagnosis of Alzheimer’s Disease with Ensemble Learning Classifier and 3D Convolutional Neural Network
description Alzheimer’s disease (AD), the most common type of dementia, is a progressive disease beginning with mild memory loss, possibly leading to loss of the ability to carry on a conversation and respond to environments. It can seriously affect a person’s ability to carry out daily activities. Therefore, early diagnosis of AD is conducive to better treatment and avoiding further deterioration of the disease. Magnetic resonance imaging (MRI) has become the main tool for humans to study brain tissues. It can clearly reflect the internal structure of a brain and plays an important role in the diagnosis of Alzheimer’s disease. MRI data is widely used for disease diagnosis. In this paper, based on MRI data, a method combining a 3D convolutional neural network and ensemble learning is proposed to improve the diagnosis accuracy. Then, a data denoising module is proposed to reduce boundary noise. The experimental results on ADNI dataset demonstrate that the model proposed in this paper improves the training speed of the neural network and achieves 95.2% accuracy in AD vs. NC (normal control) task and 77.8% accuracy in sMCI (stable mild cognitive impairment) vs. pMCI (progressive mild cognitive impairment) task in the diagnosis of Alzheimer’s disease.
format article
author Peng Zhang
Shukuan Lin
Jianzhong Qiao
Yue Tu
author_facet Peng Zhang
Shukuan Lin
Jianzhong Qiao
Yue Tu
author_sort Peng Zhang
title Diagnosis of Alzheimer’s Disease with Ensemble Learning Classifier and 3D Convolutional Neural Network
title_short Diagnosis of Alzheimer’s Disease with Ensemble Learning Classifier and 3D Convolutional Neural Network
title_full Diagnosis of Alzheimer’s Disease with Ensemble Learning Classifier and 3D Convolutional Neural Network
title_fullStr Diagnosis of Alzheimer’s Disease with Ensemble Learning Classifier and 3D Convolutional Neural Network
title_full_unstemmed Diagnosis of Alzheimer’s Disease with Ensemble Learning Classifier and 3D Convolutional Neural Network
title_sort diagnosis of alzheimer’s disease with ensemble learning classifier and 3d convolutional neural network
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/ef23e82ff19944889342ed459fd053fc
work_keys_str_mv AT pengzhang diagnosisofalzheimersdiseasewithensemblelearningclassifierand3dconvolutionalneuralnetwork
AT shukuanlin diagnosisofalzheimersdiseasewithensemblelearningclassifierand3dconvolutionalneuralnetwork
AT jianzhongqiao diagnosisofalzheimersdiseasewithensemblelearningclassifierand3dconvolutionalneuralnetwork
AT yuetu diagnosisofalzheimersdiseasewithensemblelearningclassifierand3dconvolutionalneuralnetwork
_version_ 1718410499654156288